Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Platelet membrane coated resiquimod nanoparticles - Cello Therapeutics

Next Previous
Drug Profile

Platelet membrane coated resiquimod nanoparticles - Cello Therapeutics

Alternative Names: CE-120; PNP-R848

Latest Information Update: 12 Nov 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Cello Therapeutics
  • Class Adjuvants; Antineoplastics; Antivirals; Imidazoles; Quinolones; Skin disorder therapies; Small molecules
  • Mechanism of Action Interferon alpha stimulants; Toll-like receptor 7 agonists; Toll-like receptor 8 agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I Solid tumours
  • Preclinical Systemic lupus erythematosus

Most Recent Events

  • 05 Sep 2024 Preclinical trials in Systemic lupus erythematosus in USA (unspecified route)
  • 05 Sep 2024 Pharmacodynamics data from preclinical studies in Systemic lupus erythematous presented at the Hypertension Scientific Session 2024 (HSS-2024)
  • 05 Jun 2024 Pharmacodynamics data from a phase I trial in Solid tumours were presented at European Association for the Study of the Liver Congress 2024 (EASL-2024)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top